Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Sunshine Biopharma (SBFM) Debt Ratio (2017 - 2021)

Sunshine Biopharma's Debt Ratio history spans 5 years, with the latest figure at 0.86 for Q4 2021.

  • For Q4 2021, Debt Ratio fell 4.98% year-over-year to 0.86; the TTM value through Dec 2021 reached 0.86, down 4.98%, while the annual FY2021 figure was 0.86, 4.98% down from the prior year.
  • Debt Ratio reached 0.86 in Q4 2021 per SBFM's latest filing, down from 1.28 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 1.28 in Q3 2021 to a low of 0.19 in Q3 2019.
  • Average Debt Ratio over 5 years is 0.61, with a median of 0.46 recorded in 2020.
  • Peak YoY movement for Debt Ratio: crashed 33.5% in 2019, then soared 245.09% in 2020.
  • A 5-year view of Debt Ratio shows it stood at 0.31 in 2017, then decreased by 12.46% to 0.27 in 2018, then crashed by 30.55% to 0.19 in 2019, then skyrocketed by 382.31% to 0.91 in 2020, then dropped by 4.98% to 0.86 in 2021.
  • Per Business Quant, the three most recent readings for SBFM's Debt Ratio are 0.86 (Q4 2021), 1.28 (Q3 2021), and 1.13 (Q2 2021).